The pharmaceutical company is undertaking three endeavors to fight Covid-19.
New Jersey-based pharmaceutical Merck announced three initiatives Tuesday to fight the novel coronavirus, including teaming up with nonprofit scientific research firm IAVI to develop a vaccine, as companies around the world race to find an effective treatment against the virus.
“COVID-19 is a global challenge and requires global solutions,” said Merck chairman and chief executive Kenneth C. Frazier in a statement. “Merck intends to make any vaccine or medicine we develop for this pandemic broadly accessible and affordable globally, and we are working now to accomplish this goal as quickly as possible.
